Researchers
Oljačić, Slavica
Results 1-20 of 135
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2026 | The design of multi-target ligands and their role in schizophrenia therapy: an update![]() | Gagić, Žarko | Article | 21aM21a |
| 2026 | Current Computational Approaches for the Discovery of Novel Anticancer Agents Targeting VEGFR and SIRT Signaling Pathways![]() | Ilić, Aleksandra | Article | 21aM21a |
| 2025 | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2025 | Protolytic Equilibria of Cetirizine in the Presence of Micelle-Forming Surfactants![]() | Popović-Nikolić, Marija | Article | 22M22 |
| 2025 | A linear solvation energy relationship analysis of selected imidazoline derivatives in reversed-phase thin-layer chromatography | Oljačić, Slavica | Article | 23M23 |
| 2025 | Consideration of electrophoretic behavior of some imidazoline and α adrenergic receptors ligands using DFT approach | Čebzan, Alen | Conference Paper | Mp. category will be shown later |
| 2025 | Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties![]() | Bagán, Andrea; López-Ruiz, Alba; Abás, Sònia; Ruiz-Cantero, Carmen M.; Vasilopoulou, Foteini; Taboada-Jara, Teresa; Griñán-Ferré, Christian; Pallàs, Mercè; Muguruza, Carolina; Diez-Alarcia, , Rebeca;
Callado, Luis F.; Entrena, José M.; Cobos, Enrique J.; Pérez, Belén; Morales-García, José A.; Molins, Elies; De Jonghe, Steven; Daelemans, Dirk; Brea, José; Val, C.; Loza, M. Isabel; Hernández-Hernández, Elena; García-Sevilla, Jesús A.; García-Fuster, M. Julia; Díaz, Caridad; Fernández-Godino, Rosario; Genilloud, Olga; Beljkaš, Milan
| Article | 21a+M21a+ |
| 2025 | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents![]() | Beljkaš, Milan | Article | 22M22 |
| 2025 | First Reported QSAR Models Of Dual HDAC6 And ROCK2 Inhibitors Employing Random Forest Regression Algorithm | Zukić, Selma; Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
| 2025 | Application of Separation Methods in Biomimetic Studies and the Determination of Physicochemical Properties of Imidazoline and αAdrenergic Receptor Ligands![]() | Oljacic, Slavica | Conference Paper | Mp. category will be shown later |
| 2025 | Application of machine learning and molecular docking to the modelling and design of HDAC6/ROCK dual inhibitors with in vitro experimental validation | Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
| 2025 | Exploring the effect of bioenvironment on the ionization of drugs using the membrane mimetic properties of differently charged micelles | Popović-Nikolić, Marija | Conference Paper | Mp. category will be shown later |
| 2025 | Computer-Aided Drug Design of novel dual histone deacetylase inhibitors | Ilić, Aleksandra | Conference Paper | Mp. category will be shown later |
| 2024 | Molecular modeling and design of new PI3K/HDAC dual inhibitors | Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
| 2024 | Evaluation of novel compounds as anti-bacterial or anti-virulence agents![]() | Filipić, Brankica | Article | 21M21 |
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling![]() | Đoković, Nemanja | Conference Paper | Mp. category will be shown later |
| 2024 | Computer-aided Drug Discovery of Epigenetic Modulators in Dual-target Therapy of Multifactorial Diseases![]() | Oljačić, Slavica | Reviews | 22M22 |
| 2024 | Acid base equilibria of olopatadine in aqueous media | Popović-Nikolić, Marija | Conference Paper | Mp. category will be shown later |
| 2024 | Understanding the ionization pattern of bilastine, histamine H1 receptor antagonist | Popović-Nikolić, Marija | Conference Paper | Mp. category will be shown later |
| 2024 | Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment![]() | Beljkaš, Milan | Conference Paper | Mp. category will be shown later |
